A recent U.S. Supreme Court decision is spurring more states to enact laws banning pharmacy benefit managers (PBMs) from reimbursing 340B pharmacies less for prescription drugs than non-340B providers, health care lawyers say in a new paper.
According to the backgrounder published by the American Health Law Association (AHLA), the high court’s unanimous decision last December in Rutledge v. Pharmaceutical Care Management Association was “a significant win for pharmacies and health care providers with pharmacy operations, and particularly providers participating in the 340B program.” K&L Gates attorneys Donald Walker, Leah D’Aurora Richardson, and Victoria K. Hamscho wrote the paper for AHLA.
A recent U.S. Supreme Court decision is spurring more states to enact laws banning pharmacy benefit managers (PBMs) from reimbursing 340B pharmacies less for prescription drugs than non-340B providers, health care lawyers say in a new paper.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
